XML 38 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Segment Reporting Information [Line Items]        
Revenue $ 182,924 $ 156,472 $ 589,450 $ 439,050
Depreciation and amortization 3,479 4,455 8,291 6,635
Segment operating income (loss) 55,287 57,918 221,188 162,086
Research
       
Segment Reporting Information [Line Items]        
Depreciation and amortization 502 1,210 1,494 1,818
Segment operating income (loss) (15,455) (17,224) (48,422) (47,989)
Molecular Diagnostics
       
Segment Reporting Information [Line Items]        
Revenue 176,191 148,384 565,335 416,304
Depreciation and amortization 2,506 2,424 5,335 3,543
Segment operating income (loss) 70,815 76,165 266,794 214,195
Companion Diagnostics
       
Segment Reporting Information [Line Items]        
Revenue 6,733 8,088 24,115 22,746
Depreciation and amortization 471 821 1,462 1,274
Segment operating income (loss) $ (73) $ (1,023) $ 2,816 $ (4,120)